Evolution of the Average Target: GlaxoSmithKline Pakistan Limited

Evolution of the Average Target - GlaxoSmithKline Pakistan Limited

Evolution of the Target Price: GlaxoSmithKline Pakistan Limited

Evolution of the Target Price - GlaxoSmithKline Pakistan Limited

Changes in Analyst Recommendations: GlaxoSmithKline Pakistan Limited

c09db47330fd2584f56017927e4e40c._owilb-Hj3efwgbqDRLGTWDVQGGpcQDEQwnnohObySY.j7lk_9nw_UPRhjeaXGeyBRe8Mij6F2OwEkG_7F7wq0eW6nbU_bbIHdT6Xw~07dbff49ca238cfa45a3857dfc79d899

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +64.4%
+1.9%
+4.41%
-0.14%
-1.64%
+7.69%
-4.18%
+21.09%
-11.31%
+1.89%
Average +8.41%
Weighted average by Cap. +2.29%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
310.22PKR
Average target price
510.00PKR
Spread / Average Target
+64.40%
High Price Target
510.00PKR
Spread / Highest target
+64.40%
Low Price Target
510.00PKR
Spread / Lowest Target
+64.40%

Analyst Consensus Detail

Analyst consensus - GlaxoSmithKline Pakistan Limited

Consensus revision (last 18 months)

Consensus revision (last 18 months) - GlaxoSmithKline Pakistan Limited
  1. Stock Market
  2. Stocks
  3. GLAXO Stock
  4. Consensus GlaxoSmithKline Pakistan Limited